Share Price and Basic Stock Data
Last Updated: October 18, 2025, 6:51 pm
| PEG Ratio | 12.70 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Clean Science & Technology Ltd operates in the specialty chemicals sector, focusing on producing eco-friendly chemicals. The company has shown significant growth in its revenue, with reported sales rising from ₹241 Cr in March 2018 to ₹936 Cr in March 2023. However, there was a decline to ₹791 Cr in March 2024, followed by a recovery to ₹967 Cr in March 2025, indicating a volatile but upward trajectory. The trailing twelve months (TTM) sales stood at ₹986 Cr, reflecting a robust performance amid industry fluctuations. Quarterly sales trends also depict variability; for instance, sales peaked at ₹248 Cr in September 2022 but fell to ₹181 Cr by September 2023. The operating profit margin (OPM) has fluctuated, standing at 40% in the most recent quarter, showcasing the operational efficiency of the company despite the revenue fluctuations. Overall, Clean Science’s revenue dynamics highlight the company’s resilience in a competitive market.
Profitability and Efficiency Metrics
The profitability of Clean Science & Technology Ltd has been commendable, with a net profit of ₹264 Cr reported for March 2025, up from ₹295 Cr in March 2023. The company has maintained a healthy return on equity (ROE) of 20.2% and return on capital employed (ROCE) of 27.3%, which are strong indicators of effective capital utilization and profitability relative to shareholder equity. The interest coverage ratio stands at an impressive 1024.52x, indicating that the company can comfortably meet its interest obligations, reflecting financial stability. However, the cash conversion cycle (CCC) has increased to 129 days for March 2025, suggesting potential inefficiencies in inventory management and accounts receivable. Despite this, the overall profitability metrics, including an OPM of 40% in the latest quarter, suggest that the company is effectively managing its costs relative to its revenues, positioning it favorably in the specialty chemicals sector.
Balance Sheet Strength and Financial Ratios
Clean Science’s balance sheet exhibits strong fundamentals, with total assets reported at ₹1,600 Cr and total liabilities at ₹1,600 Cr, indicating a balanced financial structure. The company’s reserves have grown from ₹186 Cr in March 2018 to ₹1,406 Cr in March 2025, reflecting robust retained earnings and a solid equity base. Borrowings remain minimal at ₹2 Cr, which contributes to a low debt-equity ratio, enhancing financial stability. The current ratio stands at 5.14, significantly above the industry average, indicating strong liquidity and the ability to cover short-term obligations. Additionally, the price-to-book value (P/BV) ratio is reported at 8.76x, suggesting that the stock is trading at a premium compared to its book value, which may indicate strong market confidence in the company’s potential. Overall, the financial ratios reveal a well-capitalized firm with a strong liquidity position and minimal leverage.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Clean Science & Technology Ltd reflects substantial promoter confidence, with promoters holding 74.96% of the shares. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have also shown increasing interest, with FIIs at 6.21% and DIIs at 5.92% as of March 2025. This trend suggests a growing confidence among institutional investors in the company’s long-term prospects. The public shareholding stands at 12.91%, with the total number of shareholders at 2,25,484, indicating a diversified investor base. While the promoter holding has slightly decreased from 78.50% in September 2022, the overall stability in shareholding suggests that investor confidence remains robust. The increasing presence of institutional investors could provide additional support to share prices and enhance liquidity in the market.
Outlook, Risks, and Final Insight
If Clean Science & Technology Ltd can sustain its profitability margins and manage its cash conversion cycle effectively, it could enhance its operational efficiency and shareholder value. Potential risks include fluctuations in raw material costs and the impact of regulatory changes in the chemicals industry, which could affect profitability. Additionally, the observed volatility in quarterly sales may pose challenges in maintaining consistent revenue growth. However, the company’s strong balance sheet and liquidity position provide a buffer against these risks. If the management can leverage its robust financial ratios to optimize operations and navigate market dynamics, Clean Science is well-positioned for sustainable growth in the specialty chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Clean Science & Technology Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 424 Cr. | 46.1 | 89.2/42.6 | 25.8 | 20.0 | 0.87 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 36.3 Cr. | 73.9 | 106/56.0 | 16.2 | 87.4 | 1.35 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 51.5 Cr. | 757 | 1,178/600 | 56.0 | 670 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,875 Cr. | 85.5 | 120/78.0 | 25.8 | 20.7 | 0.59 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 756 Cr. | 303 | 453/241 | 27.1 | 91.1 | 0.82 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 13,147.68 Cr | 753.99 | 47.43 | 178.12 | 0.42% | 12.99% | 25.41% | 6.44 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 234 | 248 | 237 | 217 | 188 | 181 | 195 | 228 | 224 | 238 | 241 | 264 | 243 |
| Expenses | 143 | 150 | 129 | 112 | 112 | 106 | 108 | 133 | 129 | 148 | 142 | 159 | 143 |
| Operating Profit | 91 | 97 | 108 | 105 | 76 | 75 | 87 | 95 | 95 | 90 | 98 | 105 | 100 |
| OPM % | 39% | 39% | 46% | 48% | 40% | 41% | 44% | 42% | 42% | 38% | 41% | 40% | 41% |
| Other Income | 2 | 3 | 13 | 13 | 13 | 6 | 8 | 14 | 10 | 11 | 5 | 12 | 13 |
| Interest | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 8 | 9 | 9 | 10 | 11 | 11 | 11 | 13 | 16 | 18 | 18 | 17 | 19 |
| Profit before tax | 85 | 92 | 112 | 108 | 79 | 69 | 83 | 95 | 89 | 83 | 85 | 100 | 95 |
| Tax % | 26% | 26% | 25% | 25% | 25% | 25% | 25% | 26% | 26% | 29% | 23% | 26% | 26% |
| Net Profit | 63 | 68 | 84 | 81 | 59 | 52 | 63 | 70 | 66 | 59 | 66 | 74 | 70 |
| EPS in Rs | 5.92 | 6.40 | 7.89 | 7.58 | 5.55 | 4.91 | 5.89 | 6.61 | 6.20 | 5.53 | 6.18 | 6.97 | 6.59 |
Last Updated: August 20, 2025, 2:35 am
Below is a detailed analysis of the quarterly data for Clean Science & Technology Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 243.00 Cr.. The value appears to be declining and may need further review. It has decreased from 264.00 Cr. (Mar 2025) to 243.00 Cr., marking a decrease of 21.00 Cr..
- For Expenses, as of Jun 2025, the value is 143.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 159.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 16.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 100.00 Cr.. The value appears to be declining and may need further review. It has decreased from 105.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 5.00 Cr..
- For OPM %, as of Jun 2025, the value is 41.00%. The value appears strong and on an upward trend. It has increased from 40.00% (Mar 2025) to 41.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 95.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2025) to 95.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
- For Net Profit, as of Jun 2025, the value is 70.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 70.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 6.59. The value appears to be declining and may need further review. It has decreased from 6.97 (Mar 2025) to 6.59, marking a decrease of 0.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:19 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 241 | 393 | 419 | 512 | 685 | 936 | 791 | 967 | 986 |
| Expenses | 167 | 257 | 234 | 253 | 385 | 533 | 459 | 579 | 593 |
| Operating Profit | 74 | 137 | 186 | 260 | 300 | 403 | 332 | 388 | 393 |
| OPM % | 31% | 35% | 44% | 51% | 44% | 43% | 42% | 40% | 40% |
| Other Income | 5 | 11 | 11 | 25 | 30 | 30 | 41 | 39 | 42 |
| Interest | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 8 | 11 | 14 | 17 | 25 | 36 | 46 | 69 | 72 |
| Profit before tax | 70 | 137 | 182 | 267 | 305 | 396 | 326 | 357 | 363 |
| Tax % | 30% | 28% | 23% | 26% | 25% | 25% | 25% | 26% | |
| Net Profit | 49 | 98 | 140 | 198 | 228 | 295 | 244 | 264 | 269 |
| EPS in Rs | 345.41 | 689.84 | 1,051.67 | 18.68 | 21.51 | 27.78 | 22.97 | 24.88 | 25.27 |
| Dividend Payout % | 12% | 15% | 2% | 134% | 15% | 18% | 22% | 24% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 42.86% | 41.43% | 15.15% | 29.39% | -17.29% | 8.20% |
| Change in YoY Net Profit Growth (%) | 0.00% | -57.14% | -1.43% | -26.28% | 14.23% | -46.67% | 25.48% |
Clean Science & Technology Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 12% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 5% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -14% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 24% |
| Last Year: | 20% |
Last Updated: September 5, 2025, 1:41 pm
Balance Sheet
Last Updated: September 10, 2025, 2:37 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 186 | 271 | 341 | 529 | 758 | 999 | 1,193 | 1,406 |
| Borrowings | 1 | 3 | 3 | 0 | 0 | 2 | 2 | 2 |
| Other Liabilities | 48 | 53 | 85 | 120 | 156 | 140 | 191 | 181 |
| Total Liabilities | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,396 | 1,600 |
| Fixed Assets | 102 | 127 | 166 | 186 | 296 | 460 | 636 | 715 |
| CWIP | 2 | 4 | 3 | 55 | 44 | 20 | 57 | 30 |
| Investments | 18 | 75 | 133 | 232 | 191 | 353 | 339 | 381 |
| Other Assets | 114 | 121 | 128 | 187 | 394 | 318 | 364 | 474 |
| Total Assets | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,396 | 1,600 |
Below is a detailed analysis of the balance sheet data for Clean Science & Technology Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,406.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,193.00 Cr. (Mar 2024) to 1,406.00 Cr., marking an increase of 213.00 Cr..
- For Borrowings, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 181.00 Cr.. The value appears to be improving (decreasing). It has decreased from 191.00 Cr. (Mar 2024) to 181.00 Cr., marking a decrease of 10.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,600.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,396.00 Cr. (Mar 2024) to 1,600.00 Cr., marking an increase of 204.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 715.00 Cr.. The value appears strong and on an upward trend. It has increased from 636.00 Cr. (Mar 2024) to 715.00 Cr., marking an increase of 79.00 Cr..
- For CWIP, as of Mar 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2024) to 30.00 Cr., marking a decrease of 27.00 Cr..
- For Investments, as of Mar 2025, the value is 381.00 Cr.. The value appears strong and on an upward trend. It has increased from 339.00 Cr. (Mar 2024) to 381.00 Cr., marking an increase of 42.00 Cr..
- For Other Assets, as of Mar 2025, the value is 474.00 Cr.. The value appears strong and on an upward trend. It has increased from 364.00 Cr. (Mar 2024) to 474.00 Cr., marking an increase of 110.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,600.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,396.00 Cr. (Mar 2024) to 1,600.00 Cr., marking an increase of 204.00 Cr..
Notably, the Reserves (1,406.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 73.00 | 134.00 | 183.00 | 260.00 | 300.00 | 401.00 | 330.00 | 386.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 55 | 61 | 53 | 82 | 57 | 76 | 77 |
| Inventory Days | 93 | 79 | 98 | 156 | 143 | 122 | 163 | 156 |
| Days Payable | 85 | 48 | 101 | 180 | 166 | 90 | 139 | 103 |
| Cash Conversion Cycle | 69 | 87 | 58 | 29 | 59 | 89 | 99 | 129 |
| Working Capital Days | 60 | 62 | 33 | 32 | 90 | 68 | 86 | 105 |
| ROCE % | 59% | 59% | 61% | 47% | 44% | 29% | 27% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Axis ELSS Tax Saver Fund | 878,470 | 0.33 | 116.78 | 878,470 | 2025-04-22 09:55:44 | 0% |
| Axis Growth Opportunities Fund | 433,022 | 0.49 | 57.56 | 433,022 | 2025-04-22 17:25:18 | 0% |
| Axis Flexi Cap Fund | 420,673 | 0.48 | 55.92 | 420,673 | 2025-04-22 09:55:44 | 0% |
| PGIM India Midcap Opportunities Fund | 365,712 | 0.49 | 48.62 | 365,712 | 2025-04-22 17:25:18 | 0% |
| Aditya Birla Sun Life Small Cap Fund | 358,838 | 1.07 | 47.7 | 358,838 | 2025-04-22 17:25:19 | 0% |
| Aditya Birla Sun Life Equity Hybrid 95 Fund | 312,209 | 0.56 | 41.5 | 312,209 | 2025-04-22 17:25:19 | 0% |
| Aditya Birla Sun Life Equity Advantage Fund | 285,714 | 0.69 | 37.98 | 285,714 | 2025-04-22 09:55:44 | 0% |
| Invesco India ELSS Tax Saver Fund | 282,015 | 1.48 | 37.49 | 282,015 | 2025-04-22 17:25:19 | 0% |
| Nippon India Retirement Fund - Wealth Creation Scheme | 170,000 | 0.75 | 22.6 | 170,000 | 2025-04-22 17:25:19 | 0% |
| Axis Multi Asset Allocation Fund | 97,315 | 1.1 | 12.94 | 97,315 | 2025-04-22 17:25:19 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 24.88 | 22.97 | 27.79 | 21.51 | 18.68 |
| Diluted EPS (Rs.) | 24.88 | 22.96 | 27.78 | 21.51 | 18.68 |
| Cash EPS (Rs.) | 31.38 | 27.29 | 31.18 | 23.86 | 20.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 133.28 | 113.24 | 95.07 | 72.34 | 50.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 133.28 | 113.24 | 95.07 | 72.34 | 50.81 |
| Revenue From Operations / Share (Rs.) | 90.96 | 74.49 | 88.08 | 64.48 | 48.24 |
| PBDIT / Share (Rs.) | 40.11 | 35.14 | 40.66 | 31.05 | 26.79 |
| PBIT / Share (Rs.) | 33.61 | 30.82 | 37.26 | 28.71 | 25.17 |
| PBT / Share (Rs.) | 33.57 | 30.73 | 37.24 | 28.69 | 25.16 |
| Net Profit / Share (Rs.) | 24.88 | 22.97 | 27.78 | 21.51 | 18.68 |
| NP After MI And SOA / Share (Rs.) | 24.88 | 22.97 | 27.78 | 21.51 | 18.68 |
| PBDIT Margin (%) | 44.09 | 47.17 | 46.15 | 48.16 | 55.53 |
| PBIT Margin (%) | 36.94 | 41.36 | 42.29 | 44.52 | 52.18 |
| PBT Margin (%) | 36.90 | 41.25 | 42.27 | 44.50 | 52.16 |
| Net Profit Margin (%) | 27.35 | 30.83 | 31.54 | 33.36 | 38.71 |
| NP After MI And SOA Margin (%) | 27.35 | 30.83 | 31.54 | 33.36 | 38.71 |
| Return on Networth / Equity (%) | 18.66 | 20.28 | 29.22 | 29.73 | 36.75 |
| Return on Capital Employeed (%) | 24.59 | 26.48 | 38.19 | 38.61 | 47.92 |
| Return On Assets (%) | 16.44 | 17.47 | 25.62 | 24.71 | 30.06 |
| Asset Turnover Ratio (%) | 0.64 | 0.62 | 0.89 | 0.86 | 0.94 |
| Current Ratio (X) | 5.14 | 4.12 | 5.46 | 4.23 | 3.87 |
| Quick Ratio (X) | 4.18 | 3.35 | 4.51 | 3.57 | 3.36 |
| Inventory Turnover Ratio (X) | 7.08 | 2.43 | 3.44 | 3.48 | 3.15 |
| Dividend Payout Ratio (NP) (%) | 20.09 | 21.76 | 18.89 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.93 | 18.32 | 16.83 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 79.91 | 78.24 | 81.11 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.07 | 81.68 | 83.17 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 1024.52 | 403.19 | 2214.97 | 2243.95 | 3127.44 |
| Interest Coverage Ratio (Post Tax) (X) | 636.59 | 264.53 | 1514.72 | 1555.39 | 2181.00 |
| Enterprise Value (Cr.) | 12383.61 | 14100.43 | 13420.03 | 21095.82 | 0.00 |
| EV / Net Operating Revenue (X) | 12.81 | 17.82 | 14.34 | 30.80 | 0.00 |
| EV / EBITDA (X) | 29.06 | 37.77 | 31.07 | 63.95 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 12.83 | 17.83 | 14.35 | 30.91 | 0.00 |
| Retention Ratios (%) | 79.90 | 78.23 | 81.10 | 0.00 | 0.00 |
| Price / BV (X) | 8.76 | 11.73 | 13.30 | 27.55 | 0.00 |
| Price / Net Operating Revenue (X) | 12.83 | 17.83 | 14.35 | 30.91 | 0.00 |
| EarningsYield | 0.02 | 0.01 | 0.02 | 0.01 | 0.00 |
After reviewing the key financial ratios for Clean Science & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.96 (Mar 24) to 24.88, marking an increase of 1.92.
- For Cash EPS (Rs.), as of Mar 25, the value is 31.38. This value is within the healthy range. It has increased from 27.29 (Mar 24) to 31.38, marking an increase of 4.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 133.28. It has increased from 113.24 (Mar 24) to 133.28, marking an increase of 20.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 133.28. It has increased from 113.24 (Mar 24) to 133.28, marking an increase of 20.04.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 90.96. It has increased from 74.49 (Mar 24) to 90.96, marking an increase of 16.47.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 40.11. This value is within the healthy range. It has increased from 35.14 (Mar 24) to 40.11, marking an increase of 4.97.
- For PBIT / Share (Rs.), as of Mar 25, the value is 33.61. This value is within the healthy range. It has increased from 30.82 (Mar 24) to 33.61, marking an increase of 2.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 33.57. This value is within the healthy range. It has increased from 30.73 (Mar 24) to 33.57, marking an increase of 2.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For PBDIT Margin (%), as of Mar 25, the value is 44.09. This value is within the healthy range. It has decreased from 47.17 (Mar 24) to 44.09, marking a decrease of 3.08.
- For PBIT Margin (%), as of Mar 25, the value is 36.94. This value exceeds the healthy maximum of 20. It has decreased from 41.36 (Mar 24) to 36.94, marking a decrease of 4.42.
- For PBT Margin (%), as of Mar 25, the value is 36.90. This value is within the healthy range. It has decreased from 41.25 (Mar 24) to 36.90, marking a decrease of 4.35.
- For Net Profit Margin (%), as of Mar 25, the value is 27.35. This value exceeds the healthy maximum of 10. It has decreased from 30.83 (Mar 24) to 27.35, marking a decrease of 3.48.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 27.35. This value exceeds the healthy maximum of 20. It has decreased from 30.83 (Mar 24) to 27.35, marking a decrease of 3.48.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.66. This value is within the healthy range. It has decreased from 20.28 (Mar 24) to 18.66, marking a decrease of 1.62.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.59. This value is within the healthy range. It has decreased from 26.48 (Mar 24) to 24.59, marking a decrease of 1.89.
- For Return On Assets (%), as of Mar 25, the value is 16.44. This value is within the healthy range. It has decreased from 17.47 (Mar 24) to 16.44, marking a decrease of 1.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has increased from 0.62 (Mar 24) to 0.64, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 5.14. This value exceeds the healthy maximum of 3. It has increased from 4.12 (Mar 24) to 5.14, marking an increase of 1.02.
- For Quick Ratio (X), as of Mar 25, the value is 4.18. This value exceeds the healthy maximum of 2. It has increased from 3.35 (Mar 24) to 4.18, marking an increase of 0.83.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.08. This value is within the healthy range. It has increased from 2.43 (Mar 24) to 7.08, marking an increase of 4.65.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.09. This value is within the healthy range. It has decreased from 21.76 (Mar 24) to 20.09, marking a decrease of 1.67.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.93. This value is below the healthy minimum of 20. It has decreased from 18.32 (Mar 24) to 15.93, marking a decrease of 2.39.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.91. This value exceeds the healthy maximum of 70. It has increased from 78.24 (Mar 24) to 79.91, marking an increase of 1.67.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.07. This value exceeds the healthy maximum of 70. It has increased from 81.68 (Mar 24) to 84.07, marking an increase of 2.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1,024.52. This value is within the healthy range. It has increased from 403.19 (Mar 24) to 1,024.52, marking an increase of 621.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 636.59. This value is within the healthy range. It has increased from 264.53 (Mar 24) to 636.59, marking an increase of 372.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 12,383.61. It has decreased from 14,100.43 (Mar 24) to 12,383.61, marking a decrease of 1,716.82.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.81. This value exceeds the healthy maximum of 3. It has decreased from 17.82 (Mar 24) to 12.81, marking a decrease of 5.01.
- For EV / EBITDA (X), as of Mar 25, the value is 29.06. This value exceeds the healthy maximum of 15. It has decreased from 37.77 (Mar 24) to 29.06, marking a decrease of 8.71.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 12.83. This value exceeds the healthy maximum of 3. It has decreased from 17.83 (Mar 24) to 12.83, marking a decrease of 5.00.
- For Retention Ratios (%), as of Mar 25, the value is 79.90. This value exceeds the healthy maximum of 70. It has increased from 78.23 (Mar 24) to 79.90, marking an increase of 1.67.
- For Price / BV (X), as of Mar 25, the value is 8.76. This value exceeds the healthy maximum of 3. It has decreased from 11.73 (Mar 24) to 8.76, marking a decrease of 2.97.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 12.83. This value exceeds the healthy maximum of 3. It has decreased from 17.83 (Mar 24) to 12.83, marking a decrease of 5.00.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Clean Science & Technology Ltd:
- Net Profit Margin: 27.35%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.59% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.66% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 636.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.18
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 41.6 (Industry average Stock P/E: 47.43)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 27.35%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Office No. 603 & 604, 6th Floor, Tower No. 15, Cybercity, Pune Maharashtra 411013 | compliance@cleanscience.co.in http://www.cleanscience.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradeep Rathi | Chairman & Non-Exe.Director |
| Mr. Ashok Boob | Managing Director |
| Mr. Siddhartha Sikchi | Executive Director |
| Mr. Krishnakumar Boob | Executive Director |
| Mr. Parth Maheshwari | Executive Director |
| Mr. Sanjay Kothari | Non Executive Director |
| Mr. Keval Doshi | Ind. Non-Executive Director |
| Ms. Madhu Dubhashi | Ind. Non-Executive Director |
| Prof. Ganapati Yadav | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Clean Science & Technology Ltd?
Clean Science & Technology Ltd's intrinsic value (as of 18 October 2025) is 899.20 which is 14.44% lower the current market price of 1,051.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 11,173 Cr. market cap, FY2025-2026 high/low of 1,640/1,032, reserves of ₹1,406 Cr, and liabilities of 1,600 Cr.
What is the Market Cap of Clean Science & Technology Ltd?
The Market Cap of Clean Science & Technology Ltd is 11,173 Cr..
What is the current Stock Price of Clean Science & Technology Ltd as on 18 October 2025?
The current stock price of Clean Science & Technology Ltd as on 18 October 2025 is 1,051.
What is the High / Low of Clean Science & Technology Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Clean Science & Technology Ltd stocks is 1,640/1,032.
What is the Stock P/E of Clean Science & Technology Ltd?
The Stock P/E of Clean Science & Technology Ltd is 41.6.
What is the Book Value of Clean Science & Technology Ltd?
The Book Value of Clean Science & Technology Ltd is 133.
What is the Dividend Yield of Clean Science & Technology Ltd?
The Dividend Yield of Clean Science & Technology Ltd is 0.57 %.
What is the ROCE of Clean Science & Technology Ltd?
The ROCE of Clean Science & Technology Ltd is 27.3 %.
What is the ROE of Clean Science & Technology Ltd?
The ROE of Clean Science & Technology Ltd is 20.2 %.
What is the Face Value of Clean Science & Technology Ltd?
The Face Value of Clean Science & Technology Ltd is 1.00.